Middle East and Africa Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others) 

The generic injectables market in the Middle East & Africa is expected to grow from US$ 3,717.72 million in 2021 to US$ 6,616.77 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.

The patents of branded injectables in several countries are likely to expire in the coming years, offering numerous remunerative opportunities to the generic injectables manufacturers. Additionally, manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities, such as those caused by the COVID-19 outbreak. Zydus Cadila is significantly reducing the price of its generic version of Remdesivir, namely Remdac. Thus, the nearing expiry of patent validity of branded drugs is likely to provide significant opportunities to generic drug manufacturers, including the companies offering generic injectables.

Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Generic Injectables Market Segmentation

The Middle East & Africa generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Middle East & Africa generic injectables market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2020. 

AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Middle East & Africa generic injectables market.

1. AstraZeneca
2. Baxter International Inc.
3. Biocon
4. Fresenius SE & Co. KGaA
5. GlaxoSmithKline plc
6. Hikma Pharmaceuticals PLC
7. Johnson and Johnson Services, Inc.
8. Lupin
9. Merck & Co., Inc.
10. Pfizer Inc.
11. Viatris Inc

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Generic Injectables Market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Generic Injectables Market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Generic Injectables Market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution